The Molecular Basis of Oligomeric Organization of the Human M3 Muscarinic Acetylcholine Receptor

被引:17
|
作者
Liste, Maria Jose Varela [1 ]
Caltabiano, Gianluigi [1 ,2 ]
Ward, Richard J. [1 ]
Alvarez-Curto, Elisa [1 ]
Marsango, Sara [1 ]
Milligan, Graeme [1 ]
机构
[1] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Autonoma Barcelona, Fac Med, Lab Med Computac, Unitat Bioestadist, Bellaterra, Spain
基金
英国医学研究理事会;
关键词
PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; PHARMACOLOGICAL CHAPERONES; SURFACE DELIVERY; TRANSFER FRET; CHOLESTEROL; HOMODIMERIZATION; DIMERIZATION;
D O I
10.1124/mol.114.096925
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors, including the M-3 muscarinic acetylcholine receptor, can form homo-oligomers. However, the basis of these interactions and the overall organizational structure of such oligomers are poorly understood. Combinations of site-directed mutagenesis and homogenous time-resolved fluorescence resonance energy transfer studies that assessed interactions between receptor protomers at the surface of transfected cells indicated important contributions of regions of transmembrane domains I, IV, V, VI, and VII as well as intracellular helix VIII to the overall organization. Molecular modeling studies based on both these results and an X-ray structure of the inactive state of the M-3 receptor bound by the antagonist/inverse agonist tiotropium were then employed. The results could be accommodated fully by models in which a proportion of the cell surface M-3 receptor population is a tetramer with rhombic, but not linear, orientation. This is consistent with previous studies based on spectrally resolved, multiphoton fluorescence resonance energy transfer. Modeling studies furthermore suggest an important role for molecules of cholesterol at the dimer + dimer interface of the tetramer, which is consistent with the presence of cholesterol at key locations in many G protein-coupled receptor crystal structures. Mutants that displayed disrupted quaternary organization were often poorly expressed and showed immature N-glycosylation. Sustained treatment of cells expressing such mutants with the muscarinic receptor inverse agonist atropine increased cellular levels and restored both cell surface delivery and quaternary organization to many of the mutants. These observations suggest that organization as a tetramer may occur before plasma membrane delivery and may be a key step in cellular quality control assessment.
引用
收藏
页码:936 / 953
页数:18
相关论文
共 50 条
  • [31] Generation of an agonistic binding site for blockers of the M3 muscarinic acetylcholine receptor
    Thor, Doreen
    Schulz, Angela
    Hermsdorf, Thomas
    Schoeneberg, Torsten
    BIOCHEMICAL JOURNAL, 2008, 412 : 103 - 112
  • [32] Identification and molecular characterization of m3 muscarinic receptor dimers
    Zeng, FY
    Wess, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 19487 - 19497
  • [33] Atropine can induce autophagy independent of the M3 muscarinic acetylcholine receptor
    Yin, Hai-Chang
    Zhuang, Wen-Zhu
    Jiang, Xin-Jie
    Liu, Di
    TRADITIONAL MEDICINE RESEARCH, 2024, 9 (07):
  • [34] Structural aspects of M3 muscarinic acetylcholine receptor dimer formation and activation
    Hu, Jianxin
    Thor, Doreen
    Zhou, Yaru
    Liu, Tong
    Wang, Yan
    McMillin, Sara M.
    Mistry, Rajendra
    Challiss, R. A. John
    Costanzi, Stefano
    Wess, Juergen
    FASEB JOURNAL, 2012, 26 (02): : 604 - 616
  • [35] Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells
    Feng, Yu-Jie
    Zhang, Bing-Yuan
    Yao, Ru-Yong
    Lu, Yun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (04) : 418 - 423
  • [36] Localization of a repressor region to the 3′ end of the promoter of the gene for the human M3 muscarinic acetylcholine receptor.
    Puhl, HL
    Kissel, K
    Mattison, J
    Williams, CL
    Aronstam, RS
    FASEB JOURNAL, 2001, 15 (05): : A1167 - A1167
  • [37] Regulation of human oligodendrocyte differentiation by muscarinic M3 receptor
    Vedia, Bansi H.
    Pol, Suyog U.
    O'Bara, Melanie A.
    Sim, Fraser J.
    FASEB JOURNAL, 2012, 26
  • [38] DIFFERENTIAL INVERSE AGONISM AT THE HUMAN MUSCARINIC M3 RECEPTOR
    Casarosa, Paola
    Kiechle, Tobias
    Bakker, Remko A.
    METHODS IN ENZYMOLOGY, VOLUME 485: CONSTITUTIVE ACTIVITY IN RECEPTORS AND OTHER PROTEINS, PART B, 2010, 485 : 81 - 101
  • [39] Structure and transcription of the human m3 muscarinic receptor gene
    Forsythe, SM
    Kogut, PC
    McConville, JF
    Fu, YP
    McCauley, JA
    Halayko, AJ
    Liu, HW
    Kao, A
    Fernandes, DJ
    Bellam, S
    Fuchs, E
    Sinha, S
    Bell, GI
    Camoretti-Mercado, B
    Solway, J
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (03) : 298 - 305
  • [40] M1–M3 muscarinic acetylcholine receptor-deficient miceNovel phenotypes
    Dinesh Gautam
    Alokesh Duttaroy
    Yinghong Cui
    Sung-Jun Han
    Chuxia Deng
    Thomas Seeger
    Christian Alzheimer
    Jürgen Wess
    Journal of Molecular Neuroscience, 2006, 30 : 157 - 160